00015550742024Q1false00015550742024Q1false12/31.7xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureiso4217:GBPaamc:noteaamc:loanaamc:counterclaimaamc:defendantaamc:employeeaamc:segment00015550742024-01-012024-03-3100015550742024-05-0800015550742024-03-3100015550742023-12-3100015550742023-01-012023-03-310001555074us-gaap:PreferredStockMember2023-12-310001555074us-gaap:CommonStockMember2023-12-310001555074us-gaap:AdditionalPaidInCapitalMember2023-12-310001555074us-gaap:RetainedEarningsMember2023-12-310001555074us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001555074us-gaap:TreasuryStockCommonMember2023-12-310001555074us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001555074us-gaap:PreferredStockMember2024-01-012024-03-310001555074us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001555074us-gaap:RetainedEarningsMember2024-01-012024-03-310001555074us-gaap:PreferredStockMember2024-03-310001555074us-gaap:CommonStockMember2024-03-310001555074us-gaap:AdditionalPaidInCapitalMember2024-03-310001555074us-gaap:RetainedEarningsMember2024-03-310001555074us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001555074us-gaap:TreasuryStockCommonMember2024-03-310001555074us-gaap:PreferredStockMember2022-12-310001555074us-gaap:CommonStockMember2022-12-310001555074us-gaap:AdditionalPaidInCapitalMember2022-12-310001555074us-gaap:RetainedEarningsMember2022-12-310001555074us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001555074us-gaap:TreasuryStockCommonMember2022-12-3100015550742022-12-310001555074us-gaap:CommonStockMember2023-01-012023-03-310001555074us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001555074us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001555074us-gaap:RetainedEarningsMember2023-01-012023-03-310001555074us-gaap:PreferredStockMember2023-03-310001555074us-gaap:CommonStockMember2023-03-310001555074us-gaap:AdditionalPaidInCapitalMember2023-03-310001555074us-gaap:RetainedEarningsMember2023-03-310001555074us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001555074us-gaap:TreasuryStockCommonMember2023-03-3100015550742023-03-310001555074aamc:System73LimitedMemberaamc:PatentAndTechnologyLicensingAgreementMember2023-10-060001555074aamc:System73LimitedMemberaamc:PatentAndTechnologyLicensingAgreementMember2023-10-062023-10-060001555074aamc:PatentAndTechnologyLicensingAgreementMember2024-01-012024-03-3100015550742014-03-3100015550742014-01-012014-03-310001555074us-gaap:SeriesAPreferredStockMember2020-02-030001555074aamc:LuxorCapitalPartnersGroupLuxorMember2020-02-032020-02-030001555074aamc:LuxorCapitalGroupLPetal.v.AltisourceAssetManagementCorporationMemberaamc:LuxorCapitalPartnersGroupLuxorMember2024-01-110001555074aamc:LuxorCapitalGroupLPetal.v.AltisourceAssetManagementCorporationMember2024-01-112024-01-110001555074aamc:LuxorCapitalGroupLPetal.v.AltisourceAssetManagementCorporationMember2024-01-110001555074aamc:NoteIssuedDueAndPayableOnCurrentYearAnniversaryOfEffectiveDateMemberaamc:LuxorCapitalGroupLPetal.v.AltisourceAssetManagementCorporationMember2024-01-112024-01-110001555074aamc:LuxorCapitalGroupLPetal.v.AltisourceAssetManagementCorporationMemberaamc:NoteIssuedDueAndPayableOnFirstYearAnniversaryOfEffectiveDateMember2024-01-112024-01-110001555074aamc:LuxorCapitalGroupLPetal.v.AltisourceAssetManagementCorporationMemberaamc:NoteIssuedDueAndPayableOnTwoYearAnniversaryOfEffectiveDateMember2024-01-112024-01-110001555074aamc:NoteIssuedDueAndPayableOnThreeYearAnniversaryOfEffectiveDateMemberaamc:LuxorCapitalGroupLPetal.v.AltisourceAssetManagementCorporationMember2024-01-112024-01-110001555074aamc:NoteIssuedDueAndPayableOnFourYearAnniversaryOfEffectiveDateMemberaamc:LuxorCapitalGroupLPetal.v.AltisourceAssetManagementCorporationMember2024-01-112024-01-110001555074aamc:LuxorCapitalGroupLPetal.v.AltisourceAssetManagementCorporationMemberaamc:NoteIssuedDueAndPayableOnFiveYearAnniversaryOfEffectiveDateMember2024-01-112024-01-110001555074aamc:LoansHeldForSaleMember2024-03-310001555074aamc:LoansHeldForSaleMember2023-12-310001555074aamc:LoanHeldForInvestmentMember2024-03-310001555074aamc:LoanHeldForInvestmentMember2023-12-310001555074aamc:LoansHeldForSaleMember2024-01-012024-03-310001555074aamc:LoanHeldForInvestmentMember2024-01-012024-03-310001555074stpr:WA2024-03-310001555074stpr:FL2024-03-310001555074stpr:AR2024-03-310001555074stpr:TX2024-03-310001555074stpr:MI2024-03-310001555074stpr:PA2024-03-310001555074aamc:OtherStateMember2024-03-310001555074us-gaap:FairValueMeasurementsRecurringMember2024-03-310001555074us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-03-310001555074us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-03-310001555074us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310001555074us-gaap:FairValueMeasurementsRecurringMember2023-12-310001555074us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-12-310001555074us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001555074us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001555074us-gaap:ValuationTechniqueDiscountedCashFlowMember2024-01-012024-03-310001555074aamc:PortfolioLoansMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-01-012024-03-310001555074aamc:FormerChiefExecutiveOfficerIndroneelChatterjeeMember2022-10-190001555074aamc:FormerChiefExecutiveOfficerIndroneelChatterjeeMember2022-10-192022-10-190001555074aamc:FormerChiefExecutiveOfficerIndroneelChatterjeeMember2022-12-292022-12-290001555074aamc:FormerChiefExecutiveOfficerIndroneelChatterjeeMember2021-05-032022-12-290001555074us-gaap:PositiveOutcomeOfLitigationMemberaamc:ErbeyHoldingCorporationEtAlVBlackrockManagementIncEtAlMember2023-03-300001555074us-gaap:PositiveOutcomeOfLitigationMemberaamc:ErbeyHoldingCorporationEtAlVBlackrockManagementIncEtAlMember2023-07-130001555074us-gaap:PositiveOutcomeOfLitigationMemberaamc:ErbeyHoldingCorporationEtAlVBlackrockManagementIncEtAlMember2023-12-310001555074us-gaap:PositiveOutcomeOfLitigationMemberaamc:ErbeyHoldingCorporationEtAlVBlackrockManagementIncEtAlMember2024-03-310001555074srt:ManagementMemberus-gaap:RestrictedStockMember2024-01-012024-03-310001555074srt:ManagementMemberus-gaap:RestrictedStockMember2023-01-012023-03-310001555074us-gaap:RestrictedStockMember2024-01-012024-03-310001555074us-gaap:RestrictedStockMember2023-01-012023-03-310001555074us-gaap:RestrictedStockMember2024-03-310001555074us-gaap:RestrictedStockMember2023-12-3100015550742023-09-082023-09-0800015550742023-09-080001555074us-gaap:RestrictedStockMember2024-01-012024-03-310001555074us-gaap:RestrictedStockMember2023-01-012023-03-310001555074us-gaap:PreferredStockMember2024-01-012024-03-310001555074us-gaap:PreferredStockMember2023-01-012023-03-3100015550742023-09-182023-09-18

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR TRANSITION PERIOD FROM __________ TO __________

(Exact name of registrant as specified in its charter)

(Address of principal executive office)

(Registrant’s telephone number, including area code)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 8, 2024, 2,554,512 shares of our common stock were outstanding (excluding 2,129,973 shares held as treasury stock).

References in this report to “we,” “our,” “us,” “AAMC,” or the “Company” refer to Altisource Asset Management Corporation and its consolidated subsidiaries, unless otherwise indicated.

Our disclosure and analysis in this Quarterly Report on Form 10-Q contain, and our officers, directors and authorized spokespersons may make, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “targets,” “predicts,” or “potential,” or the negative of these words and phrases or similar words or phrases that are predictions of or indicate future events or trends and that do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans or intentions.

The forward-looking statements contained in this report reflect our current views about future events and are subject to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause our actual business, operations, results or financial condition to differ significantly from those expressed in any forward-looking statement. Factors that may materially affect such forward-looking statements include, but are not limited to:

Our ability to develop and implement new businesses or, to the extent such businesses are developed, our ability to make them successful or sustain the performance of any such businesses;

•Current inflationary economic and macro-economic and geopolitical events, and market conditions that can affect our business;

•Our ability to develop and implement a new business with respect to assets and rights acquired by the Company through the non-exclusive patent and technology licensing agreement between the Company and System73 Limited, and that the Company will achieve its expectations with respect to the patents and other intellectual property associated therewith;

•Our ability to monetize our remaining loan portfolio; and

•The failure of our information technology systems, a breach thereto, and our ability to integrate and improve those systems at a pace fast enough to keep up with competitors and security threats.

While forward-looking statements reflect our good faith beliefs, assumptions, and expectations, they are not guarantees of future performance. Such forward-looking statements speak only as of their respective dates, and we assume no obligation to update them to reflect changes in underlying assumptions, new information or otherwise. For a further discussion of these and other factors that could cause our future results to differ materially from any forward-looking statements, please see Item 1A. Risk Factors in this Quarterly Report on Form 10-Q and “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets as of March 31, 2024 and 2023:

Following a full year of ALG’s operations, our Board of Directors mandated a comprehensive review of the Company’s mortgage platform to improve the performance of the business. The review involved assessments of operational efficiency and capacity issues, opportunities for cost reductions, strategies for improving liquidity, among other initiatives, all with a view toward enhancing financial performance. While the Company will retain the ability to originate and purchase loans in the future, it does not anticipate doing so other than on a very selective basis.

On October 6, 2023, the Company signed a non-exclusive patent and technology licensing agreement (“the PTL Agreement”) with System73 Limited (“System 73”), an entity controlled and managed by the 53.6% owners of the Company’s common stock. Under the PTL Agreement, the Company obtained a non-exclusive license for a set of patents for a control system which seeks to optimize the efficiency of electric vehicles (“EVs”). The Company’s investment in the EV business will be its principal line of business on a go-forward basis.

In addition, the PTL Agreement contemplates certain equity incentives for System73 based on performance. The PTL Agreement sets out “AAMC Common Stock Milestones”, defined as each instance where the average closing price of the Company’s common stock for the preceding twenty (20) day period reaches an amount equal to or in excess of a multiple of $100 (i.e., $100, $200, $300, etc.). Upon the occurrence of each such AAMC Common Stock Milestone, System 73 would be awarded the number of shares of AAMC Common Stock equal to ten percent (10%) of the AAMC fully diluted Shares. Consistent with New York Stock Exchange rules, any equity award under the PTL Agreement will be subject to stockholder approval.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). All wholly owned subsidiaries are included, and all intercompany accounts and transactions have been eliminated.

In management's opinion, the unaudited interim condensed consolidated financial statements contain all adjustments (all of which are normal and recurring in nature) considered necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. The interim results are not necessarily indicative of results for a full year. We have omitted certain notes and other information from the interim condensed consolidated financial statements presented in this Quarterly Report on Form 10-Q as permitted by SEC rules and regulations. These condensed consolidated financial statements should be read in conjunction with our annual consolidated financial statements included within our Annual Report on Form 10-K for the year ended December 31, 2023.

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

Through our ALG business line we previously originated and purchased alternative loans. These loans are either classified as held for investment or held for sale depending upon the determination of management. We have elected to measure these alternative loans at fair value on a loan by loan basis. This option is available when we first recognize a financial asset. Subsequent changes in the fair value of these loans will be recorded in our Condensed Consolidated Statements of Operations in the period of the change. Purchased loans, also known as correspondent loans, can be bought with a net strip interest component in that the seller of the loan will receive an agreed upon percentage of the coupon interest generated from the sold loan. This strip component is reflected as service and asset management expense on the Condensed Consolidated Statements of Operations.

A fair value measurement represents the price at which an orderly transaction would occur between willing market participants at the measurement date. We estimate the fair values of the loans held for investment or sale based on available inputs from the marketplace. The market for the loans that we have is generally illiquid. Establishing fair values for illiquid assets is inherently subjective and is often dependent upon our estimates and modeling assumptions. In circumstances where relevant market inputs cannot be obtained, increased analysis and management judgment are required to estimate fair value. This generally requires us to establish internal assumptions about future cash flows and appropriate risk-adjusted discount rates. Regardless of the valuation inputs we apply, the objective of fair value measurement for assets is unchanged from what it would be if markets were operating at normal activity levels and/or transactions were orderly; that is, to determine the current exit price. When the Company sells a loan, a gain or loss will be recognized at the time of the sale in net income for the difference between the fair value and the book value. The fair value is measured as the agreed upon selling price from the contractual agreement with the buyer.

See Note 2 - Loans Held for Sale or Investment at Fair Value for further discussion on fair value measurements.

Interest for these loans is recognized as revenue based on the stated coupon when earned and deemed collectible or until a loan becomes more than 90 days past due, at which point the loan is placed on nonaccrual status and any accrued interest is reversed against interest income. When a seriously delinquent loan previously placed on nonaccrual status has been cured, meaning all delinquent principal and interest have been remitted by the borrower, the loan will be placed back on accrual status. Interest accrued as of period end is included within loans held for sale, at fair value or loans held for investment, at fair value in the Condensed Consolidated Balance Sheets as applicable.

We evaluate transfers of loans held for sale or investment at fair value under the guidance in Financial Accounting Standards Board Accounting Standards Codification ("ASC") Topic No. 860, "Transfers and servicing of financial assets" ("ASC 860"), and account for such transfers as sales when three conditions in ASC 810-10-45-5 have been met. That is, we account for transfers of such financial assets as sales when the assets have been isolated from the Company, when the transferee has the right to pledge or exchanges the assets it receives and there are no restrictions on the transferee that constrain such right, and when the Company has no effective control over the transferred financial assets. There were no transfers of financial assets during the three months ended March 31, 2024. The Company realized an aggregate gain totaling $0.01 million and an aggregate loss of $0.28 million for the three months ended March 31, 2023 on loans held for sale and loans held for investment, respectively, which is included in realized gains on loans held for sale, net and realized losses on loans held for investment, net, respectively, in the accompanying Condensed Consolidated Statement of Operations. Each of the loans transferred during the three months ended March 31, 2023 qualified for sale accounting under ASC 860, as each of the loans was transferred to a third-party "as is" in exchange for cash, and the Company has no continuing involvement with the transferred financial assets or the transferees.

During the first quarter of 2014, we issued 250,000 shares of convertible preferred stock for $250.0 million to institutional investors. Under the Certificate of Designations of the Series A Shares (the “Certificate”), we had the option to redeem all of the Series A Shares on March 15, 2020 and on each successive five-year anniversary of March 15, 2020 thereafter. In connection with these same redemption dates, each holder of our Series A Shares had the right to give notice requesting us to redeem all of the Series A Shares held by such holder out of legally available funds. Under the terms of the Certificate, the Company would have been required to redeem if it had legally available funds to redeem all, but not less than all, of the Series A Shares requested by a holder to be redeemed on a redemption date. The redemption right would have been exercisable in connection with each redemption date every five years until the mandatory redemption date in 2044.

The Series A Shares were not entitled to receive dividends. The Series A Shares were convertible into shares of our common stock at a conversion price of $1,250 per share (or an exchange rate of 0.8 shares of common stock for Series A Share), subject to certain anti-dilution adjustments. For a further description of other terms and conditions in respect of the Series A Shares, please refer to Note 1 - Organization and Basis of Presentation to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 and the Certificate of Designations for the Series A Convertible Preferred Stock referenced as Exhibit 3.3 in this Quarterly Report.

Between January 31, 2020 and February 3, 2020, we received purported notices from all of the holders of our Series A Shares requesting us to redeem an aggregate of $250.0 million liquidation preference of our Series A Shares on March 15, 2020. We did not have legally available funds to redeem all, but not less than all, of the Series A Shares on March 15, 2020. As a result, we did not believe, under the terms of the Certificate, that we were obligated to redeem any of the Series A Shares under the Certificate.

–Luxor (plaintiff) v. AAMC (defendant)

On February 3, 2020, a complaint was filed in New York state court by Luxor Capital Group LP and various related entities collectively “Luxor”), each a holder of AAMC Series A Shares, against AAMC claiming breach of contract, specific performance, unjust enrichment, and related damages and expenses. Luxor sought an order requiring AAMC to redeem its Series A Shares, damages of up to $150,000,000, as well as payment of its costs and expenses in the lawsuit.

On December 1, 2022, following extensive briefing and oral arguments by each side, the trial court denied the parties’ respective summary judgment motions.

On June 13, 2023, the Appellate Division - First Department issued a unanimous decision in favor of AAMC and directed the trial court to enter judgment dismissing Luxor’s complaint. On July 19, 2023, Luxor filed a request for a further appeal to the New York Court of Appeals, and AAMC filed an opposition thereto on August 7, 2023.

As noted below, pursuant to a settlement agreement entered into by the parties dated January 11, 2024, this litigation has been terminated and dismissed with prejudice. See “Settlement activities”.

–AAMC (plaintiff) v. Nathaniel Redleaf (defendant)

On October 31, 2022, AAMC filed suit in the Superior Court of the Virgin Islands (subsequently removed to federal court), against former Company director Nathaniel Redleaf alleging disclosure of confidential information to Luxor in breach of the fiduciary duty he owed to AAMC. AAMC sought a number of remedies, including compensatory damages and disgorgement of any benefit received by Luxor or Mr. Redleaf as a result of such alleged breaches.

As noted below, all litigation with Mr. Redleaf and Luxor has been resolved and dismissed with prejudice. See “Settlement activities”.

From February 2021 through July 2022, the Company entered into a series of settlement agreements with various institutional holders of the Series A Shares resulting in the redemption and cancellation thereof. For information concerning the terms and conditions of these settlements, see Note 1 - Organization and Basis of Presentation to the Consolidated Financial Statements included in our Annual Report on From 10-K for the year ended December 31, 2023.

On January 11, 2024 (the “Effective Date”), AAMC entered into a settlement agreement with Luxor and Mr. Redleaf, pursuant to which the parties agreed as follows:

•Luxor surrendered all 144,212 shares of AAMC Series A Convertible Preferred Stock it held to AAMC. Luxor and AAMC agreed that their related Securities Purchase Agreement dated March 13, 2014, along with the Certificate of Designations dated March 17, 2014 attached thereto, are void and all rights thereunder are extinguished.

•The Company shall provide the following consideration to Luxor

▪A $1,000,000 cash payment within five days of the Effective Date, plus

▪Three Promissory Notes in the following principal amounts and durations:

•Each Note bears annual interest at either 7.5% on a cash basis or 10% paid-in-kind (“PIK”) basis, at the election of AAMC and the carrying amount of such notes approximates fair value as of March 31, 2024. The Company shall refrain from making common stock repurchases or issuing dividends at any time the PIK option is in effect and is subject to certain additional covenants enumerated in the Notes.

•The Company shall also pay Luxor 50% of any proceeds received in respect of its damage claims in the action brought by Erbey Holding Corporation pending in USVI Superior Court with case number SX-2018-CV-146, up to a cumulative payout cap to Luxor of $50,000,000.

•The parties agreed and stipulated to dismissal with prejudice of the following actions: (i) Luxor Capital Group LP, et. al v. Altisource Asset Management Corporation filed in the Supreme Court of the State of New York in the County of New York, with index number 650746/2020 (including Luxor’s withdrawal of its pending request for further appellate review by the New York Court of Appeals), and (ii) Altisource Asset Management Corporation v. Nathaniel Redleaf et. al pending in the United States District Court for the District of the Virgin Islands, with case number 1:23-cv-00002. The parties exchanged mutual releases of their respective claims relating to the aforesaid actions, SPA and Certificate, as applicable, and agreed that their settlement shall not constitute or be construed as an admission that any of the parties violated the law, breached any contract or committed any wrong whatsoever.

For a discussion of our recently issued accounting standards, please see Note 1 - Organization and Basis of Presentation - “Recently issued accounting standards” in our Annual Report on Form 10-K for the year ended December 31, 2023.

In March 2024, the Securities and Exchange Commission (the “SEC”) adopted the final rules that will require certain climate-related information in registration statements and annual reports. In April 2024, the SEC voluntarily stayed the new rules as a result of pending legal challenges. The new rules include a requirement to disclose material climate-related risks, descriptions of board oversight and risk management activities, the material impacts of these risks on a registrants’ strategy, business model and outlook, and any material climate-related targets or goals, as well as material effects of severe weather events and other natural conditions and greenhouse gas emissions. Prior to the stay in the new rules, they would have been effective for annual periods beginning January 1, 2025, except for the greenhouse gas emissions disclosure which would have been effective for annual periods beginning January 1, 2026. The Company is currently evaluating the impact of these rules on its disclosures.

Our loan portfolio consists of business purpose loans secured by single family, multifamily and commercial real estate that were acquired from third party originators or issued by us. The composition of the loan portfolio by classification as of March 31, 2024 and December 31, 2023, is summarized in the table below ($ in thousands):

(1) Construction holdbacks include in process accounts such as payments, advances, interest reserve, accrued interest and other accounts.

The loan portfolio consists of 10 loans at March 31, 2024, with a weighted average coupon of 10.1%, of which the Company receives a net yield of 9.9% after taking into account the strip interest to the sellers of the loans. The weighted average life of the portfolio is approximately 0.4 years past maturity. Two loans represent 75% of the total principal outstanding at March 31, 2024. There were six loans on nonaccrual status or 90 days or more past due at March 31, 2024, with a fair value of $5.2 million. These loans have an unpaid principal balance of $7.7 million at March 31, 2024.

As of March 31, 2024, we have commenced formal foreclosure proceedings on six loans with an aggregate fair value of $4.6 million in order to force the sale of the real estate that serves as collateral for such loans. We expect that the sale of the collateral will allow us to recover the full repayment of the outstanding loans and accrued interest as of March 31, 2024.

The table below represents activity within the loan portfolio by classification for the period shown ($ in thousands):

The composition of the total loan commitment by state as of March 31, 2024 is summarized below ($ in thousands):

For financial reporting purposes of our alternative loans, we follow a fair value hierarchy established under GAAP that is used to determine the fair value of financial instruments. This hierarchy prioritizes relevant market inputs in order to determine an “exit price” at the measurement date, or at the price at which an asset could be sold or a liability could be transferred in an orderly process that is not a forced liquidation or distressed sale.

In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. Our assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured.

The following table presents the assets that are reported at fair value on a recurring basis as of March 31, 2024 and December 31, 2023, as well as the fair value of hierarchy of the valuation inputs used to measure fair value. We did not have any liabilities to report at fair value on a recurring basis as of March 31, 2024 and December 31, 2023.

The estimated fair value for our business purpose loans is determined using the discounted cash flow model (“DCF”) to estimate the net present value of the future cash flows expected from each loan. For performing loans, the DCF is based on the future expected cash flows of each loan in accordance with its contractual terms net of the strip component. Cash flows for performing loans with construction holdbacks incorporate the draws to complete the required improvements to the underlying property securing the loan. For nonaccrual loans, the estimated cash flows are based on the current fair value of the collateral of the loans, in which the Company will utilize a third-party appraisal to determine the fair value (Level 3).

On a loan-by-loan basis, the weighted average discount rate range utilized for the DCF applied to the net yield to be received by the Company was 10.0% which is greater the overall yield on the portfolio of 9.9%, resulting in the decrease in value of the portfolio at March 31, 2024. The determination of the discount rate was based on analysis of the current interest rates charged for business purpose loans in conjunction with the increase in rates for other underlying base rates such as the 10-year U.S. treasury bond and the 30 day Secured Overnight Financing Rate ("SOFR") (Level 3). For nonaccrual loans, the discount applied to the value of the collateral was based on available market information on REO sales transaction as of the valuation date (Level 3).

We did not transfer any assets from one level to another level during the three months ended March 31, 2024 or 2023.

We evaluate the change in fair value attributable to instrument-specific credit risk as the excess of the total change in fair value over the change in fair value attributable to changes in the risk-free rate. Instrument-specific credit risk had an immaterial impact on the change in fair value recognized for loans held during the three months ended March 31, 2024 and 2023.

We currently lease office space under operating leases in Christiansted, St. Croix, U.S. Virgin Islands and Bengaluru, India. Prior to the termination of the lease in October 2023, we also leased space in Tampa, Florida.

As of March 31, 2024 and December 31, 2023, our weighted average remaining lease term, including applicable extensions, was 3.0 years and 3.3 years respectively and we applied a discount rate of 7.0% to our office leases. We determined the discount rate for each lease to be either the discount rate stated in the lease agreement or our estimated rate that we would charge to finance real estate assets.

During each of the three month periods ended March 31, 2024 and 2023, we recognized rent expense of $0.1 million. We had no short-term rent expense for the three months ended March 31, 2024 or 2023. We include rent expense as a component of general and administrative expenses in the Condensed Consolidated Statements of Operations. We had no finance leases during the three months ended March 31, 2024 or 2023.

The following table presents a maturity analysis of our operating leases as of March 31, 2024 ($ in thousands):

(1)Excludes the three months ended March 31, 2024

Right-of-use assets are periodically reviewed for impairment losses under ASC 360-10, “Property, plant, and equipment,” to determine whether a right-of-use asset is impaired, and if so, the amount of impairment loss to recognize. We did not recognize any impairments of right-of-use assets for the three months ended March 31, 2024 and 2023.

Information regarding reportable legal proceedings is contained in the “Commitments and Contingencies” note in the financial statements provided in our Annual Report on Form 10-K for the year ended December 31, 2023. We establish reserves for specific legal proceedings when we determine that the likelihood of an outcome is probable and the amount of loss can be reasonably estimated. We do not currently have any reserves for our legal proceedings.  The following updates and restates the description of the previously reported matters:

Please refer to Note 1 - Organization and Basis of Presentation – Sections “Related litigation” and “Settlement activities”.

On May 3, 2021, the Company’s former CEO Indroneel Chatterjee commenced an arbitration against the Company and each of its directors. The arbitration complaint alleged that the Company’s termination of Mr. Chatterjee’s employment for cause was in breach of his employment agreement. The complaint also alleged certain extra-contractual claims against the Company. On October 19, 2022, following extensive briefing by the parties, the arbitrator dismissed all of Mr.

Chatterjee's then remaining claims and granted summary judgment on one of the Company's counterclaims requiring Mr. Chatterjee to pay the Company $400,000 (the return of half of his initial signing bonus). On December 29, 2022, the arbitrator entered a final order which granted additional award of fees, costs and interest to the Company in the amount of over $1 million, bringing the Company's total judgment against Mr. Chatterjee to approximately $1.6 million. The Company has taken steps to attempt to enforce the judgment against Mr. Chatterjee and waives no rights or remedies with respect thereto.

On April 12, 2018, an action was filed in the Superior Court of the Virgin Islands, Division of St. Croix under the caption Erbey Holding Corporation, et al. v. Blackrock Financial Management Inc., et al., case number SX-2018-CV-146. The action was initially filed by Plaintiffs Erbey Holding Corporation, John R. Erbey Family Limited Partnership, by its general partner Jupiter Capital, Inc., Salt Pond Holdings, LLC, Munus, L.P., Carisma Trust, by its trustee, Venia, LLC, and Tribue Limited Partnership (collectively, the “HoldCo Plaintiffs”). AAMC joined in the action as an additional named Plaintiff pursuant to Court order dated March 30, 2023.

The action was filed against Defendants Blackrock Financial Management, Inc., Blackrock Investment Management, LLC, Blackrock Investments, LLC, Blackrock Capital Management, Inc., Blackrock, Inc, Pacific Investment Management Company LLC, PIMCO Investments, LLC and John and Jane Does 1-10.

The complaint alleges that Defendants, aided by their agents and co-conspirators, engaged in an unlawful enterprise and conspiracy to harm Plaintiffs and related companies, including Ocwen Financial Corporation (“Ocwen”), by damaging their operations, business relationships and standing in the industry.

As set out in the complaint, the alleged wrongful and malicious conduct of Defendants, which included fraudulent disparagement and targeted short-selling, constitute common law intentional torts and violations of Section 605 of the Virgin Islands Criminally Influenced and Corrupt Organizations Act (“CICO”). AAMC and the HoldCo Plaintiffs seek compensatory damages in amounts reflecting the substantial diminution in value of their stock and stock holdings, respectively, and/or lost profits, plus lost future market value appreciation and profits. Any direct or indirect compensatory damages awarded under CICO are subject to automatic trebling. The action also seeks punitive damages of up to nine times any compensatory amounts based on the egregious nature of the alleged intentional torts, as well as an award of attorneys’ fees and other expenses incurred in prosecuting the case.

Defendants filed multiple motions that sought to dismiss the case on various alleged grounds, including that Plaintiffs failed to adequately plead their respective statutory and common law tort claims and that the Court allegedly lacked personal jurisdiction over Defendants.

On July 13, 2023, a court-appointed Staff Master issued a comprehensive recommendation that all of AAMC’s legal claims should be permitted to proceed and that the Court should exercise personal jurisdiction over four of the five named Blackrock-entity Defendants and both of the named PIMCO-entity Defendants. The Staff Master recommended that Blackrock, Inc. be dismissed for lack of personal jurisdiction.

On December 4, 2023, the trial judge adopted the Staff Master’s recommendation and overruled Defendants’ objections thereto. The trial judge certified the findings of jurisdiction for a potential interlocutory discretionary appeal. The Virgin Islands Supreme Court has not yet determined whether or not to accept Defendants’ appeal. The trial judge also entered a final order dismissing Blackrock, Inc., thus permitting an appeal by Plaintiffs as of right to the Virgin Islands Supreme Court. Briefing in Plaintiff’s appeal concluded on April 17, 2024.

On February 27, 2024, the trial judge denied Defendants’ request for a stay of discovery during the pendency of appellate matters before the Virgin Islands Supreme Court and directed the Staff Master to conduct a discovery conference on an expedited basis. The Staff Master held a discovery conference and on April 4, 2024, entered a Discovery and Scheduling Plan which provides for all discovery to be completed in the fall of 2025.

At this time, we are not able to predict the ultimate outcome of this matter, nor can we estimate the range of possible damages to be awarded to AAMC, if any. As such, we have not recorded a gain contingency for this matter at March 31, 2024 or December 31, 2023.

A special grant of stock options and restricted stock was made to certain employees of Altisource Portfolio Solutions N.A. (“ASPS”) related to our separation from ASPS under the 2012 Special Equity Incentive Plan (the “2012 Special Plan”). We included no share-based compensation in our condensed consolidated financial statements for the portion of these grants made to ASPS employees. The shares of restricted stock became fully vested and were issued during 2017. Dividends received on restricted stock are forfeitable and are accumulated until the time of vesting at the same rate and on the same date as on shares of common stock. Upon the vesting of stock options and restricted stock, we may withhold up to the statutory minimum to satisfy the resulting employee tax obligation.

We recorded no compensation expense related to grants of stock options for the three months ended March 31, 2024 and 2023, respectively.

As of both March 31, 2024 and December 31, 2023 we had no outstanding options issued under all of our share-based compensation plans or as inducement awards.

During the three months ended March 31, 2024 and 2023, we granted no shares of service-based restricted stock to members of management. We recorded no compensation expense related to our share-based compensation plan for the three months ended March 31, 2024. We recorded $0.2 million of compensation expense related to our share-based compensation for the three months ended March 31, 2023. As of March 31, 2024 and December 31, 2023, we had an no unrecognized share-based compensation cost to be recognized.

We are domiciled in the USVI and are obligated to pay taxes to the USVI on our income. We applied for tax benefits from the USVI Economic Development Commission (“EDC”) and received our certificate of benefits (“the EDC Certificate”), effective as of February 1, 2013. Pursuant to the Certificate, so long as we comply with its provisions, we will receive a 90% tax reduction on our USVI-sourced income taxes until 2043. By letter dated April 13, 2023, the EDC approved an extension of the temporary full-time employment waiver (the “Waiver”) of the Company’s minimum employment requirements to five full-time USVI employees for the period from January 1, 2023 through June 30, 2023. By letter dated February 19, 2024, the EDC approved an additional extension for the period July 1, 2023 to December 31, 2024. At March 31, 2024, the Company met the minimum employment requirements required under the provisions of the Waiver.

As of March 31, 2024 and December 31, 2023, we accrued no interest or penalties associated with any unrecognized tax benefits, nor did we recognize any interest expense or penalties during the three months ended March 31, 2024 and 2023.

The Company recorded a $14,000 tax benefit and a book loss of $3.1 million for the first quarter of 2024. The material differences between the effective tax rate and the statutory tax rate are the EDC benefit discussed above and the fact that the USVI EDC is in a full valuation allowance position and incurred a current quarter loss.

The following table sets forth the components of basic and diluted income (loss) per share ($ in thousands, except share and per share amounts):

On September 8, 2023, the Company’s Board of Directors approved a 70% stock dividend. Each stockholder of record on September 18, 2023 received a dividend of seven tenths additional share of common stock for each then-held share, with any fractional shares rounded up, to be distributed after close of trading on October 31, 2023. The Company’s common stock began trading on a stock-adjusted basis on November 1, 2023. The par value of the Company’s common stock was not affected by the split and remained at $0.01 per share. The computations of basic and diluted EPS have been adjusted on a retrospective basis for all periods presented.

We excluded the items presented below from the calculation of diluted income (loss) per share as they were antidilutive for the periods indicated, as the Company had a net loss from operations for each period presented ($ in thousands):

The Company has two reportable segments: Loan Operations and Control System Commercialization. ALG is our primary business in the Loan Operations segment. Activity in the Control System Commercialization segment began during the first quarter of 2024 and is comprised entirely of electric vehicle intellectual property development expenses. The segment has no assets or liabilities at March 31, 2024.

Management has evaluated the impact of all subsequent events through the issuance of these condensed consolidated financial statements and determined that there were no subsequent events requiring adjustment or disclosure in the financial statements.

Following a full year of ALG’s operations, our Board of Directors mandated a comprehensive review of the Company’s mortgage platform to improve the performance of the business. The review involved assessments of operational efficiency and capacity issues, opportunities for cost reductions, strategies for improving liquidity, among other initiatives, all with a view toward enhancing financial performance. The Company made significant progress in reducing costs and streamlining operations. This included an across-the-board employee right-sizing, reducing expenditures for third-party professional services, reducing reliance on lines of credit and significantly reducing our investment in loans held for sale and investment. While the Company will retain the ability to originate and purchase loans in the future, it does not anticipate doing so other than on a very selective basis.

On October 6, 2023, the Company signed a non-exclusive patent and technology licensing agreement (“the PTL Agreement”) with System73 Limited (“System 73”), an entity controlled and managed by the 53.6% owners of the Company’s common stock. Under the PTL Agreement, the Company obtained a non-exclusive license for a set of patents for a control system which seeks to optimize the efficiency of electric vehicles (“EVs”). The patents cover algorithms which optimize the utilization of multiple motors not only at a point in time but over the entire trip. The Company’s investment in the EV business will be its principal line of business on a go-forward basis.

Electric motors have very narrow ranges of torque and speed where they are highly efficient. Outside of that range, efficiency generally rapidly deteriorates. By employing multiple motors with differing peak efficiency ranges in an electric vehicle, the overall efficiency can be improved. The patent covers algorithms which optimize the utilization of multiple motors not only at a point in time but over the entire trip.

There are two primary value propositions which are being pursued in this venture:

•Consumer - automotive and light truck to extend range and performance; and

•Commercial and industrial both delivery and construction/mining equipment – minimize downtime for both expensive personnel and equipment during recharging.

In addition, the PTL Agreement contemplates certain equity incentives for System73 based on performance. The PTL Agreement sets out “AAMC Common Stock Milestones”, defined as each instance where the average closing price of the Company’s common stock for the preceding twenty (20) day period reaches an amount equal to or in excess of a multiple of $100 (i.e., $100, $200, $300, etc.). Upon the occurrence of each such AAMC Common Stock Milestone, System 73 would be awarded the number of shares of AAMC Common Stock equal to ten percent (10%) of the AAMC fully diluted Shares.

Consistent with New York Stock Exchange rules, any equity award under the PTL Agreement will be subject to stockholder approval.

Our operating results are affected by various factors and market conditions, including the following:

Our revenues primarily consist of loan interest income and origination fees earned on our loans held for sale and investment, net realized gains or losses on loans held for sale, along with other ancillary fees earned from the loan portfolio.

Our expenses consist primarily of salaries and employee benefits, legal and professional fees, general and administrative expenses, servicing and asset management expense, acquisition charges, operational interest expense, direct loan expense, and loan sales and marketing expense, other loan related expenses and electric vehicle intellectual property development. Salaries and employee benefits include the base salaries, incentive bonuses, medical coverage, retirement benefits, non-cash share-based compensation and other benefits provided to our employees for their services. Legal and professional fees include services provided by third-party attorneys, accountants and other service providers of a professional nature. General and administrative expenses include costs related to the general operation and overall administration of our business as well as non-cash share-based compensation expense related to restricted stock awards to our Directors. Servicing and asset management expenses include loan commissions. Acquisition charges reflect professional fees incurred solely for the purpose of assisting the Company in the identification of target companies and the subsequent due diligence, valuation, and deal structuring services required to properly assess the viability of the target companies. Operational interest expense, direct loan expense, and loan sales and marketing expense are fees related to loans or the line of credit.

Other income (expense) primarily relates to income or expense recognized in the change of fair value of loans, change in the fair value of equity securities, gain and dividends on equity securities.

The following sets forth discussion of our results of operations for the three months ended March 31, 2024 and 2023. Our results of operations for the periods presented are not indicative of our expected results in future periods.

Loan interest income decreased to $0.2 million from $2.0 million for the three months ended March 31, 2024 and 2023, respectively, as a result of the lower number of loans held for sale and investment during the first three months of 2024.

Loan fee income decreased to $6,000 from $0.1 million for the three months ended March 31, 2024 and 2023, respectively, as a result of the lower number of loans held for sale and investment during the first three months of 2024.

Realized gains on loans held for sale, net, were $0 and $10,000 for the three months ended March 31, 2024 and 2023, respectively, due to the lower number of loans held for sale during the first three months of 2024.

Salaries and employee benefits decreased to $0.2 million from $1.9 million for the three months ended March 31, 2024 and 2023, respectively. The 2024 decrease is due to an across-the-board employee right-sizing during the fourth quarter of 2023.

Legal fees decreased to $51,000 from $0.4 million for the three months ended March 31, 2024 and 2023, respectively. This decrease was primarily due to higher costs in 2023 related to the Luxor litigation and employment issues. We incurred no acquisition costs for the three months ended March 31, 2024 and 2023, respectively. Professional fees of $0.4 million were flat period-over-period.

General and administrative expenses decreased to $0.3 million from $0.9 million for the three months ended March 31, 2024 and 2023, respectively, as a result of reducing costs and streamlining operations, including an across-the-board employee right-sizing, and reducing expenditures for third-party professional services.

Servicing and asset management expense decreased to $0.1 million from $0.2 million for the three months ended March 31, 2024 and 2023, respectively, as a result of the lower number of loans held for sale and investment during the first three months of 2024.

Interest expense includes interest incurred on our margin account, line of credit and amortized commitment fees. We incurred no interest expenses during the three months ended March 31, 2024 as the Company has been debt free since the fourth quarter of 2023. Interest expense of $1.1 million was recorded for the three months ended March 31, 2023.

Direct loan expense decreased to $7,000 from $0.3 million for the three months ended March 31, 2024 and 2023, respectively, as a result of the lower number of loans held for sale and investment during the first three months of 2024. Direct loan expenses include loan broker fees, inspection fees, title search and other fees.

We incurred no loan sales and marketing expense during the three months ended March 31, 2024 , compared to $0.4 million for the three months ended March 31, 2023, due to our retrenchment from the loan business during the second half of 2023. Loan sales and marketing expenses include expenses related to the promotion and exposure to leads which may result in originations of loans.

Electric vehicle intellectual property development costs were $1.9 million for the three months ended March 31, 2024. The company did not incur any electric vehicle intellectual property developments costs in prior periods, as electric vehicle development saw its first period of operations in 2024.

We recognized a $0.1 million in expense for the change in the fair value of loans during the three months ended March 31, 2024. We recognized $0.8 million in income for the change in the fair value of loans during the three months ended March 31, 2023.

We incurred no realized losses on loans held for investment, during the three months ended March 31, 2024, while $0.3 losses were recognized on loans held for investment, net, for the three months ended March 31, 2023.

As of March 31, 2024, we had cash and cash equivalents of $6.7 million compared to $8.7 million as of December 31, 2023. We believe these sources of liquidity are sufficient to enable us to meet anticipated short-term (one-year) liquidity requirements. Our ongoing cash expenditures consist of: salaries and employee benefits, legal and professional fees, lease obligations, other general and administrative expenses and investment in electric vehicle intellectual property. Certain account balances exceed FDIC insurance coverage and, as a result, there is a concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. To mitigate this risk, we maintain our cash and cash equivalents at large national or international banking institutions.

On March 31, 2024, our loans held for sale, at fair value, was $2.7 million, compared to $4.5 million at December 31, 2023. The reduction was driven by our decision to liquidate our loan portfolio. These loans primarily relate to loans originated by ALG and are included net of loan holdbacks, accrued interest, payments and advances in process and market valuation amounts.

On March 31, 2024, our loans held for investment, at fair value, was $4.5 million, compared to $5.6 million at December 31, 2023. The reduction was driven by our decision to liquidate our loan portfolio and phase out our ALG business line. These loans primarily relate to business purpose bridge loans for the transitioning of real estate properties and are included net of loan holdbacks, accrued interest, in process and market valuation amounts.

As of March 31, 2024, a total of $275.2 million in shares of our common stock have been repurchased under the authorization by our Board of Directors to repurchase up to $300.0 million in shares of our common stock.  Repurchased shares are held as treasury stock and are available for general corporate purposes. As of March 31, 2024, we had an aggregate of $24.8 million shares remaining available for repurchase under our Board-approved repurchase plan. 

The Company did not repurchase any shares during the three months ended March 31, 2024. The Company repurchased 27,441 shares for $1.5 million during the three months ended March 31, 2023.

We report and analyze our cash flows based on operating activities, investing activities and financing activities. The following table summarizes our cash flows for the periods indicated ($ in thousands):

Net cash used in operating activities for the three months ended March 31, 2024 and 2023, consisted primarily of additional fundings of held for sale loans, interest receivable, payment of ongoing salaries and benefits, and general corporate expenses in excess of revenues.

Net cash provided by investing activities for the three months ended March 31, 2024 and 2023, consisted primarily of the proceeds from sales and principal payments on loans held for investment, offset by additional fundings of loans held for investment.

Net cash used in financing activities during the three months ended March 31, 2024, consisted primarily of cash used in the conversion of preferred stock. Net cash used in financing activities for the three months ended March 31, 2023, consisted primarily of funds borrowed and repaid under the Company’s line of credit, and cash used in the repurchase of common stock.

We had no off-balance sheet arrangements as of March 31, 2024 or December 31, 2023.

See Item 1 - Financial statements (unaudited) - Note 1 - Organization and Basis of Presentation - “Recently issued accounting standards.”

For a discussion of our critical accounting judgments, please see Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - “Critical Accounting Judgments” in our Annual Report on Form 10-K for the year ended December 31, 2023; and Note 1 - Organization and Basis of Presentation and Note 2 - Loans Held for Sale or Investment at Fair Value of the condensed consolidated interim financial statements.

Market risk includes risks that arise from changes in interest rates, foreign currency exchange rates, commodity prices, equity prices and other market changes that affect market sensitive instruments.

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company's filings under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and to ensure that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Our Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this quarterly report. Based upon that evaluation, management has determined that the Company's disclosure controls and procedures were effective as of March 31, 2024.

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives as specified above. Management does not expect, however, that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.

For a description of the Company’s legal proceedings, refer to Item 1 - Financial Statements (Unaudited) - Note 1 - Organization and Basis of Presentation, Settlement activities and Note 4 - Commitments and Contingencies of the condensed consolidated interim financial statements included in this Quarterly Report on Form 10-Q for material developments of legal proceedings to which the Company is a party.

Our risk factors reflected in our December 31, 2023 Form 10-K (filed on March 29, 2024) have not materially changed. For additional information regarding our risk factors, you should carefully consider the risk factors disclosed in “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023.

None.

None.

    

Not applicable.

During the fiscal quarter ended March 31, 2024, none of the Company’s directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

On May 13, 2024, Richard G. Rodick notified the Company that he will retire from the position of Chief Financial Officer, effective August 15, 2024. Mr. Rodick will continue to serve as the Company’s Chief Financial Officer until that date (such date, subject to change, the “Separation Date”) to assist with a successful transition of responsibilities. Mr. Rodick will continue to earn his current annual base salary through the Separation Date. The Company has identified Michael L. DelGiacco as Mr. Rodick’s successor. Mr. DelGiacco brings over 20 years of experience as a global finance executive across multiple industries. He currently resides with his family in the U.S. Virgin Islands. Mr. DelGiacco has been hired as Senior Vice President, Finance and will transition to the Chief Financial Officer role effective August 15, 2024. There are no family relationships between Mr. DelGiacco and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

* Filed herewith.

** Indicates the exhibit is being furnished, not filed, with this report.

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.